Clinical Trial: To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants

U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT06808802) titled 'To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants' on Jan. 31.

Brief Summary: The purpose of this study J1I-MC-GZQE is to measure the effect of retatrutide on the pharmacokinetics (PK) of metoprolol in healthy participants.

Study Start Date: Feb., 2025

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Retatrutide

Administered subcutaneously (SC)

DRUG: Metoprolol

Administered orally

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Eli Lilly and Company

Disclaimer: Curated by HT Syndication....